Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

A team of scientists at Novartis synthesize new complement C5 convertase inhibitors

Oct. 8, 2014

Researchers in London prepare novel SSAO inhibitors for COPD and other disorders

Oct. 8, 2014

Sanofi divulges new SGK1 inhibitors

Oct. 8, 2014

Researchers at Oncodesign patent novel RIP-2 inhibitors

Oct. 8, 2014

AbbVie discloses novel CDK9/cyclin-T1 inhibitors for cancer

Oct. 8, 2014

Canadian group synthesizes novel PCSK9 inhibitors for LDL-C

Oct. 7, 2014

New PDE10A inhibitors patented by Merck & Co.

Oct. 7, 2014

Novel agents investigated for fibrosis

Oct. 7, 2014

Researchers at Agios Pharmaceuticals patent novel agents for cancer and anemia

Oct. 7, 2014

Oryzon Genomics patents novel DDR1 antibodies for cancer

Oct. 7, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...